Search research articles
Contact Us
Filters
Showing results (161-170 of 268) with videos related to
Page
of 27
Sort By:
Cancer Research
|
January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions
Emiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib - Results from the RET-MAP Registry
Arianna Marinello, Julia K Rotow, Meghanne Lomibao, et al.
Nature Communications
|
March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation
Soo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, et al.
Annals of the American Thoracic Society
|
February 21, 2026
The Complementary Roles of EBUS-Guided Needle Aspiration, Mini-Forceps, and Cryobiopsy in the Investigation of Mediastinal Lesions
Or Kalchiem-Dekel, Brie E Kezlarian-Sachs, Xiaoyue Ma, et al.
JCO Precision Oncology
|
November 16, 2023
Amplification of Wild-Type <i>RET</i> Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib
Malini M Gandhi, Biagio Ricciuti, Guilherme Harada, et al.
The New England Journal of Medicine
|
June 1, 2026
Selpercatinib in Early-Stage <i>RET</i> Fusion-Positive Non-Small-Cell Lung Cancer
Yi-Long Wu, Maximilian Hochmair, Yi Yang, et al.
European Journal of Endocrinology
|
March 25, 2022
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
Steven G Waguespack, Alexander Drilon, Jessica J Lin, et al.
The Journal of Molecular Diagnostics : JMD
|
May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens
Mark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Nature Reviews. Clinical Oncology
|
October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directions
Susana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 268) with videos related to
Sort By:
Page
of 27
Cancer Research
|
January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions
Emiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib - Results from the RET-MAP Registry
Arianna Marinello, Julia K Rotow, Meghanne Lomibao, et al.
Nature Communications
|
March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 14, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation
Soo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, et al.
Annals of the American Thoracic Society
|
February 21, 2026
The Complementary Roles of EBUS-Guided Needle Aspiration, Mini-Forceps, and Cryobiopsy in the Investigation of Mediastinal Lesions
Or Kalchiem-Dekel, Brie E Kezlarian-Sachs, Xiaoyue Ma, et al.
JCO Precision Oncology
|
November 16, 2023
Amplification of Wild-Type <i>RET</i> Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib
Malini M Gandhi, Biagio Ricciuti, Guilherme Harada, et al.
The New England Journal of Medicine
|
June 1, 2026
Selpercatinib in Early-Stage <i>RET</i> Fusion-Positive Non-Small-Cell Lung Cancer
Yi-Long Wu, Maximilian Hochmair, Yi Yang, et al.
European Journal of Endocrinology
|
March 25, 2022
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
Steven G Waguespack, Alexander Drilon, Jessica J Lin, et al.
The Journal of Molecular Diagnostics : JMD
|
May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens
Mark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.
Nature Reviews. Clinical Oncology
|
October 1, 2024
Two decades of advances in clinical oncology - lessons learned and future directions
Susana Banerjee, Christopher M Booth, Eduardo Bruera, et al.
Page
of 27